Buy WEGOVY 0.25MG Online in USA - Lowest Price $230.00
Configure Prescription
About WEGOVY 0.25MG
Wegovy 0.25MG is a once-weekly starting dose of semaglutide used for chronic weight management. It helps the body adjust to treatment before gradually increasing to higher doses.
What is it used for?
Wegovy 0.25MG contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk. It is specifically approved for long-term weight management in adults with obesity or overweight with weight-related medical conditions.
The 0.25MG dose is the initial starter dose, typically used for the first 4 weeks of treatment. It is not considered a maintenance dose but helps:
Reduce appetite
Increase feelings of fullness
Slow stomach emptying
Prepare the body for higher therapeutic doses
Wegovy is administered as a subcutaneous injection once weekly in the abdomen, thigh, or upper arm, on the same day each week.
How to use
- Helps initiate weight loss therapy safely
- Improves appetite control
- Gradual dose escalation reduces gastrointestinal side effects
- Convenient once-weekly dosing
Side Effects
Common side effects:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Mild abdominal discomfort
- Decreased appetite
Serious but rare side effects:
- Pancreatitis
- Gallbladder problems
- Severe dehydration
- Possible thyroid tumor risk (in predisposed individuals)
